Expert discusses anti-inflammatory agents for atopic, vernal conjunctivitis

SAN FRANCISCO — Stephen Pflugfelder, MD, professor and James and Margaret Elkins Chair in Ophthalmology at Baylor College of Medicine, discussed using topical anti-inflammatory agents to manage atopic and vernal conjunctivitis in a presentation at Cornea Subspecialty Day at the American Academy of Ophthalmology annual meeting.
“The pathology of allergic conditions varies between seasonal allergy conjunctivitis and atopic and vernal conjunctivitis,” he said. “Seasonal/allergy involves innate inflammatory cells and mediators. There’s an immediate reaction with

Full Story →